On the other hand, resistant cells secrete reduced amount of GMCSF, which recruits dendritic cells and in turn present tumor antigens to cytotoxic T lymphocytes, thus inducing a systemic tumor-directed immune response [94]. The gene discussed is CSF2; the disease is neoplasm.